Cerebellar hematoma in severe hemophilia with inhibitor on emicizumab prophylaxis: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-1947
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cerebellar hematoma in severe hemophilia with inhibitor on emicizumab prophylaxis: a case report ; volume:17 ; number:1 ; day:23 ; month:2 ; year:2023 ; pages:1-4 ; date:12.2023
Journal of medical case reports ; 17, Heft 1 (23.2.2023), 1-4, 12.2023
- Urheber
-
Albattat, Sami
Alabdultaif, Abbas
Albattat, Fatimah
Albattat, Batla
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13256-023-03783-7
- URN
-
urn:nbn:de:101:1-2023041421080725654690
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Albattat, Sami
- Alabdultaif, Abbas
- Albattat, Fatimah
- Albattat, Batla
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China
Pharmacokinetic model-based assessment of factor IX prophylaxis treatment regimens in severe hemophilia B
Facial Hematoma: An Atypical Bleeding Site for Acquired Hemophilia
Femoral Fractures in Severe Hemophilia
Real-world experience of emicizumab prophylaxis in Korean children with severe hemophilia A without inhibitors
Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia
Spontaneous Spinal Subdural Hematoma Secondary to Hemophilia A and Zanubrutinib
Letter to the Editor Regarding “Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China”
Adherence and Cost Effectivity of Home-Based Prophylaxis Over Institutionalized Prophylaxis in Patients with Hemophilia
Hemispheric infarct following a cerebellar hematoma: A rare coincidence
Nonacog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Moderately Severe or Severe Hemophilia B in India
Spinal subdural hematoma revealing hemophilia A in a child: A case report
Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China
Pharmacokinetic model-based assessment of factor IX prophylaxis treatment regimens in severe hemophilia B
Facial Hematoma: An Atypical Bleeding Site for Acquired Hemophilia
Femoral Fractures in Severe Hemophilia
Real-world experience of emicizumab prophylaxis in Korean children with severe hemophilia A without inhibitors
Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia
Spontaneous Spinal Subdural Hematoma Secondary to Hemophilia A and Zanubrutinib
Letter to the Editor Regarding “Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China”
Adherence and Cost Effectivity of Home-Based Prophylaxis Over Institutionalized Prophylaxis in Patients with Hemophilia
Hemispheric infarct following a cerebellar hematoma: A rare coincidence
Nonacog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Moderately Severe or Severe Hemophilia B in India
Spinal subdural hematoma revealing hemophilia A in a child: A case report
Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China
Pharmacokinetic model-based assessment of factor IX prophylaxis treatment regimens in severe hemophilia B
Facial Hematoma: An Atypical Bleeding Site for Acquired Hemophilia
Femoral Fractures in Severe Hemophilia
Real-world experience of emicizumab prophylaxis in Korean children with severe hemophilia A without inhibitors
Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia
Spontaneous Spinal Subdural Hematoma Secondary to Hemophilia A and Zanubrutinib
Letter to the Editor Regarding “Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China”
Adherence and Cost Effectivity of Home-Based Prophylaxis Over Institutionalized Prophylaxis in Patients with Hemophilia
Hemispheric infarct following a cerebellar hematoma: A rare coincidence
Nonacog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Moderately Severe or Severe Hemophilia B in India